English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
The potentials of uncariae ramulus cum uncis for the treatment of migraine: Targeting cgrp in the trigeminovascular system Journal article
Chong, Cheong Meng, Zhong, Zhangfeng, Vong, Chi Teng, Wang, Shengpeng, Lu, Jin Jian, Zhong, Haijing, Su, Huanxing, Wang, Yitao. The potentials of uncariae ramulus cum uncis for the treatment of migraine: Targeting cgrp in the trigeminovascular system[J]. Current Neuropharmacology, 2020, 19(7), 1090-1100.
Authors:  Chong, Cheong Meng;  Zhong, Zhangfeng;  Vong, Chi Teng;  Wang, Shengpeng;  Lu, Jin Jian; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.8/7.1 | Submit date：2021/09/13
Cgrp  Inflammation  Migraine  Nitric Oxide  Trigeminovascular System  Uncariae Ramulus Cum Uncis  
9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model Journal article
Ju,Yaojun, Tam,Kin Yip. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model[J]. Neuropharmacology, 2020, 181, 108354.
Authors:  Ju,Yaojun;  Tam,Kin Yip
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:4.6/4.5 | Submit date：2021/03/04
Cholinesterase  Amyloid Beta  Dual Inhibition  Multifunction  Alzheimer's Disease  
The potentials of Uncariae Ramulus Cum Uncis for treatment of migraine: Targeting CGRP in the trigeminovascular system Journal article
Chong, C. M., Zhong, Z., Vong, C. T., Wang, S., Lu, J., Zhong, H., Su, H. X., Wang, Y. T.. The potentials of Uncariae Ramulus Cum Uncis for treatment of migraine: Targeting CGRP in the trigeminovascular system[J]. Current Neuropharmacology, 2020, 1090-1100.
Authors:  Chong, C. M.;  Zhong, Z.;  Vong, C. T.;  Wang, S.;  Lu, J.; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3 | Submit date：2022/07/27
Cgrp  Uncariae Ramulus Cum Uncis  Inflammation  Migraine  Nitric Oxide  Trigeminovascular System  
SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease Journal article
Wu, Xiaoli, Kosaraju, Jayasankar, Zhou, Wei, Tam, Kin Yip. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease[J]. NEUROPHARMACOLOGY, 2018, 131, 351-363.
Authors:  Wu, Xiaoli;  Kosaraju, Jayasankar;  Zhou, Wei;  Tam, Kin Yip
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:4.6/4.5 | Submit date：2018/10/31
Amyloid Beta  Aggregation  Alzheimer's Disease  3xtg-ad  Neuroprotection  Sh-sy5y  
SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease Journal article
Wu, X., Kosaraju, J., Zhou, W., Tam, K. Y.. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease[J]. Neuropharmacology, 2018, 351-363.
Authors:  Wu, X.;  Kosaraju, J.;  Zhou, W.;  Tam, K. Y.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:4.6/4.5 | Submit date：2022/07/28
Amyloid β  Aggregation  Alzheimer’s Disease  3xtg-ad  Neuroprotection  Sh-sy5y  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo B., Hu S., Zheng C., Wang H., Luo F., Li H., Cui W., Yang X., Cui G., Mak S., Choi T.C.-L., Ma E.D.-L., Wang Y., Lee S.M.Y., Zhang Z., Han Y.. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. Neuropharmacology, 2017, 126, 12-24.
Authors:  Guo B.;  Hu S.;  Zheng C.;  Wang H.;  Luo F.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20 | Submit date：2018/11/06
Monoamine Oxidase-b  Myocyte Enhancer Factor 2d  Neuroprotection  Parkinson's Disease  Su4312  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo, Baojian, Hu, Shengquan, Zheng, Chengyou, Wang, Hongyu, Luo, Fangcheng, Li, Haitao, Cui, Wei, Yang, Xifei, Cui, Guozhen, Mak, Shinghung, Choi, Tony Chung-Lit, Ma, Edmond Dik-Lung, Wang, Yuqiang, Lee, Simon Ming Yuen, Zhang, Zaijun, Han, Yifan. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. NEUROPHARMACOLOGY, 2017, 126, 12-24.
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng; et al.
View | Adobe PDF | Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.6/4.5 | Submit date：2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo B., Hu S., Zheng C., Wang H., Luo F., Li H., Cui W., Yang X., Cui G., Mak S., Choi T.C.-L., Ma E.D.-L., Wang Y., Lee S.M.Y., Zhang Z., Han Y.. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. Neuropharmacology, 2017, 126, 12-24.
Authors:  Guo B.;  Hu S.;  Zheng C.;  Wang H.;  Luo F.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20 | Submit date：2018/11/06
Monoamine Oxidase-b  Myocyte Enhancer Factor 2d  Neuroprotection  Parkinson's Disease  Su4312  
Forkhead box O transcription factors as possible mediators in the development of major depression Journal article
Wang, HT, Quirion, R, Little, PJ, Cheng, YF, Feng, ZP, Sun, HS, Xu, JP, Zheng, WH. Forkhead box O transcription factors as possible mediators in the development of major depression[J]. NEUROPHARMACOLOGY, 2015, 99, 527-537.
Authors:  Wang, HT;  Quirion, R;  Little, PJ;  Cheng, YF;  Feng, ZP; et al.
Favorite | TC[WOS]:46 TC[Scopus]:54  IF:4.6/4.5 | Submit date：2019/01/10
Foxo  Neurogenesis  Neuronal Atrophy  Major Depression  Pi3k/akt  
Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801 Journal article
Linden A.-M., Storvik M., Lakso M., Haapasalo A., Lee D., Witkin J.M., Sei Y., Castren E., Wong G.. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801[J]. Neuropharmacology, 2001, 40(4), 469-481.
Authors:  Linden A.-M.;  Storvik M.;  Lakso M.;  Haapasalo A.;  Lee D.; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date：2018/12/18
Cerebral Cortex  Cloning  Dizocilpine  Phencyclidine  Tyrosine Kinase